156 related articles for article (PubMed ID: 30526051)
1. Brinzolamide-brimonidine fixed combination for the prevention of intraocular pressure elevation after phacoemulsification.
Georgakopoulos CD; Kagkelaris K; Pagoulatos D; Plotas P; Makri OE
Eur J Ophthalmol; 2020 Mar; 30(2):293-298. PubMed ID: 30526051
[TBL] [Abstract][Full Text] [Related]
2. Brinzolamide-timolol fixed combination for the prevention of intraocular pressure elevation after phacoemulsification.
Georgakopoulos CD; Makri OE; Plotas P; Pharmakakis N
Clin Exp Ophthalmol; 2013; 41(7):662-7. PubMed ID: 23432730
[TBL] [Abstract][Full Text] [Related]
3. Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
Topouzis F; Goldberg I; Bell K; Tatham AJ; Ridolfi A; Hubatsch D; Nicolela M; Denis P; Lerner SF
Eur J Ophthalmol; 2021 Jan; 31(1):103-111. PubMed ID: 31595773
[TBL] [Abstract][Full Text] [Related]
4. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
5. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
6. Brimonidine-timolol versus brinzolamide-timolol for treatment of elevated intraocular pressure after phacoemulsification surgery.
Balsak S; Kaydu A; Erdem S; Fuat Alakus M; Ozkurt ZG
Int Ophthalmol; 2018 Aug; 38(4):1583-1589. PubMed ID: 28674856
[TBL] [Abstract][Full Text] [Related]
7. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification.
Kir E; Cakmak H; Dayanir V
Can J Ophthalmol; 2008 Oct; 43(5):559-62. PubMed ID: 18982032
[TBL] [Abstract][Full Text] [Related]
8. Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.
Nguyen QH; McMenemy MG; Realini T; Whitson JT; Goode SM
J Ocul Pharmacol Ther; 2013 Apr; 29(3):290-7. PubMed ID: 23425430
[TBL] [Abstract][Full Text] [Related]
9. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.
Feldman RM; Katz G; McMenemy M; Hubatsch DA; Realini T
Am J Ophthalmol; 2016 May; 165():188-97. PubMed ID: 26940161
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.
Ermis SS; Ozturk F; Inan UU
Eye (Lond); 2005 Mar; 19(3):303-7. PubMed ID: 15258611
[TBL] [Abstract][Full Text] [Related]
12. Medical control of intraocular pressure after phacoemulsification.
Dayanir V; Ozcura F; Kir E; Topaloğlu A; Ozkan SB; Aktunç T
J Cataract Refract Surg; 2005 Mar; 31(3):484-8. PubMed ID: 15811735
[TBL] [Abstract][Full Text] [Related]
13. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
[TBL] [Abstract][Full Text] [Related]
14. Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.
Greig SL; Deeks ED
Drugs Aging; 2015 Mar; 32(3):251-60. PubMed ID: 25732405
[TBL] [Abstract][Full Text] [Related]
15. Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.
Fechtner RD; Myers JS; Hubatsch DA; Budenz DL; DuBiner HB
Eye (Lond); 2016 Oct; 30(10):1343-1350. PubMed ID: 27367743
[TBL] [Abstract][Full Text] [Related]
16. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
[TBL] [Abstract][Full Text] [Related]
18. 24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial.
Weinreb RN; Bacharach J; Fechtner RD; Kahook MY; Wirta D; Burmaster S; Meng X; Hubatsch DA
Ophthalmology; 2019 Aug; 126(8):1095-1104. PubMed ID: 30403988
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
Borazan M; Karalezli A; Akman A; Akova YA
J Cataract Refract Surg; 2007 Nov; 33(11):1941-5. PubMed ID: 17964402
[TBL] [Abstract][Full Text] [Related]
20. Brinzolamide plus brimonidine for the treatment of glaucoma: an update.
Chew SK; Skalicky SE; Goldberg I
Expert Opin Pharmacother; 2014 Nov; 15(16):2461-71. PubMed ID: 25267543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]